Whilst there are numerous studies that investigate the role of CD4+ Tregs in alleviating GVHD, future studies should seek to determine the efficacy of other regulatory cells such as KIR+CD8+ T cells and MDSCs. The gene discussed is CD4; the disease is graft versus host disease.